The Trump administration yesterday handed Bayer another win, urging the Supreme Court in a new brief to side with the German pesticide company in a high-stakes legal case that could wipe out thousands of cancer lawsuits and potentially billions of dollars in liability tied to glyphosate-based Roundup weed killer. Three out of nine U.S. officials who signed the brief previously worked for law firms that have represented Bayer, raising questions about whether the Trump administration is providing special favors and benefits to Bayer and siding with a foreign corporation against Americans with cancer. In the new filing, the Justice Department and Environmental Protection Agency urged the Court to rule in Bayer's favor on the central legal issue: whether federal approval of a pesticide label under federal law preempts state failure-to-warn claims. If the Court accepts that argument, individuals would be barred from suing Bayer under state law for failing to warn that Roundup may cause cancer. The salvo for Bayer is the latest in a series of favorable actions the Trump administration has provided to Bayer. On February 18, the White House invoked the Defense Production Act to guarantee supplies of glyphosate-based herbicides and elemental phosphorus, a raw element used in production of fertilizers, pesticides, herbicides, and a wide range of industrial and military chemicals. Our Bayer lobby tracker provides information about ... 45 lobbyists registered to lobby for Bayer.